With this equity back-testing module your can estimate the performance of a buy and hold strategy of RedHill Biopharma Ltd and determine expected loss or profit from investing in RedHill Biopharma over given investment horizon. Additionally take a look at RedHill Biopharma Hype Analysis, RedHill Biopharma Correlation, RedHill Biopharma Valuation, RedHill Biopharma Volatility as well as analyze RedHill Biopharma Alpha and Beta and RedHill Biopharma Performance.
|Horizon||30 Days Login to change|
RedHill Biopharma 'What if' Analysis
October 19, 20180.00
December 18, 20180.00
If you would invest 0.00 in RedHill Biopharma on October 19, 2018 and sell it all today you would earn a total of 0.00 from holding RedHill Biopharma Ltd or generate 0.0% return on investment in RedHill Biopharma over 60 days. RedHill Biopharma is related to or competes with Kamada Ltd, Compugen Ltd, Evogene Ltd, Kadimastem Ltd, and D N. RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late ...
RedHill Biopharma Upside/Downside Indicators
RedHill Biopharma Market Premium Indicators
RedHill Biopharma Backtested Returns
Macroaxis considers RedHill Biopharma to be not too risky. RedHill Biopharma maintains Sharpe Ratio (i.e. Efficiency) of -0.1272 which implies RedHill Biopharma had -0.1272% of return per unit of risk over the last 2 months. Macroaxis philosophy towards forecasting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. RedHill Biopharma exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to check RedHill Biopharma Coefficient Of Variation of
(2,219) and Risk Adjusted Performance of (0.05) to confirm risk estimate we provide. Macroaxis gives RedHill Biopharma performance score of 0 on a scale of 0 to 100. The organization holds Beta of -0.9789 which implies . Even though it is essential to pay attention to RedHill Biopharma current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Macroaxis philosophy towards forecasting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. RedHill Biopharma exposes twenty-one different technical indicators which can help you to evaluate its performance. RedHill Biopharma has expected return of -0.4316%. Please be advised to check RedHill Biopharma Downside Deviation, Standard Deviation, Information Ratio, as well as the relationship between Coefficient Of Variation and Variance to decide if RedHill Biopharma past performance will be repeated at some point in the near future.
|15 days auto-correlation||(0.54)|
|Spearman Rank Test||-0.09|
RedHill Biopharma lagged returns against current returns
Current and Lagged Values
RedHill Biopharma regressed lagged prices vs. current prices
Current vs Lagged Prices
RedHill Biopharma Lagged Returns
Currently Active Assets on Macroaxis
Purchased over 90 shares of
Purchased over 90 shares of
Purchased over 50 shares of
Purchased few shares of
Additionally take a look at RedHill Biopharma Hype Analysis, RedHill Biopharma Correlation, RedHill Biopharma Valuation, RedHill Biopharma Volatility as well as analyze RedHill Biopharma Alpha and Beta and RedHill Biopharma Performance. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.